23 May 2013
Keywords: Amgen, Micromet, M&A, BiTE antibodies, Leukemia, Non-Hodgkin's lymphoma
Article | 27 January 2012
Adding to the strong start this year for M&A activity in the Pharma/Biotech sector, USA-based Amgen (Nasdaq: ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 January 2012
26 January 2012
25 January 2012
© 2013 thepharmaletter.com